E
Elahe Keyhani
Researcher at Islamic Azad University of Mashhad
Publications - 22
Citations - 188
Elahe Keyhani is an academic researcher from Islamic Azad University of Mashhad. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 7, co-authored 21 publications receiving 154 citations.
Papers
More filters
Journal ArticleDOI
The Genotoxic and Cytotoxic Effects of Bisphenol-A (BPA) in MCF-7 Cell Line and Amniocytes.
Seyed Mohsen Aghajanpour-Mir,Ebrahim Zabihi,Haleh Akhavan-Niaki,Elahe Keyhani,Iman Bagherizadeh,Sajjad Biglari,Farkhondeh Behjati +6 more
TL;DR: BPA showed that BPA could lead to chromosomal aberrations in both ER-dependent and independent pathways at some concentrations or in cell types yet not reported, and could probably be considered as a facilitator for some predisposed cells to be cancerous by raising the chromosome instability levels.
Journal ArticleDOI
Overexpression of her-2/neu in malignant mammary tumors; translation of clinicopathological features from dog to human.
TL;DR: Overexpression of the HER-2/neu gene in MMGTs results in similar biological behavior as that of HBC; as a result, these tumors have can be considered to have important similarities in clinicopathological characteristics.
Journal ArticleDOI
Angiogenesis markers in breast cancer--potentially useful tools for priority setting of anti-angiogenic agents.
Elahe Keyhani,Ahad Muhammadnejad,Farkhondeh Behjati,Fereidoon Sirati,Faranak Khodadadi,Masoud Karimlou,Fatemeh Aghakhani Moghaddam,Reza Pazhoomand +7 more
TL;DR: Patients with simultaneous mutations of HER-2 and p53 genes, those with ERBB2 molecular subtype and also younger women seem more eligible for obtaining anti-angiogenic agents in breast cancer via assessment of tumor angiogenesis by the microvessel density (MVD) method and associations with clinicopathological characteristics.
Journal ArticleDOI
The influence of the BCL11A polymorphism on the phenotype of patients with beta thalassemia could be affected by the beta globin locus control region and/or the Xmn1-HBG2 genotypic background.
Maryam Neishabury,Fahimeh Zamani,Elahe Keyhani,Azita Azarkeivan,Seyedeh Sedigheh Abedini,Masumeh Sadat Eslami,Setareh Talebi Kakroodi,Mahjoobeh Jafari Vesiehsari,Hossein Najmabadi +8 more
TL;DR: It is suggested that the LCR background, by governing the state of BCL11A binding to this region, plays a more significant role in determining the thalassemia phenotype than the level of B CL11A protein expression, that might be influenced by single nucleotide polymorphisms in intronic regions of the BCL 11A gene.
Journal ArticleDOI
Mutation analysis of the DBC2 gene in sporadic and familial breast cancer.
Mina Ohadi,Mehdi Totonchi,Paula Maguire,A. Lindblom,R. Habibi,B. Afshin Alavi,Elahe Keyhani,Hossein Najmabadi +7 more
TL;DR: The sequence variations found within the promoter and 5′-UTR region of the gene warrant expression analysis and screening more tumor samples at this region, and no deleterious mutations were detected in the coding sequence.